HHL-B:CA:TSX-Harvest Healthcare Leaders Income ETF (CAD)

ETF | Others |

Last Closing

CAD 9.79

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.96K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.14 (-0.49%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.31B
PHYS-U:CA Sprott Physical Gold Trust

-0.13 (-0.65%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

CAD 4.54B
XEQT:CA iShares Core Equity Portfolio

-0.03 (-0.09%)

CAD 4.46B
HXT-U:CA Horizons S&P/TSX 60 Index ETF

+1.25 (+2.85%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.03 (+0.29%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.07 (+0.31%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 2.53B

ETFs Containing HHL-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.64% 74% C 68% D+
Dividend Return -1.34% 5% F 2% F
Total Return 13.30% 68% D+ 57% F
Trailing 12 Months  
Capital Gain 13.31% 52% F 52% F
Dividend Return -0.66% 4% F 2% F
Total Return 12.66% 47% F 45% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.53% 58% F 48% F
Dividend Return 2.62% 58% F 42% F
Total Return 0.09% 50% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 4.68% 76% C+ 91% A-
Risk Adjusted Return 56.02% 79% B- 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike